Huiskamp, L. F. J., Chargi, N., Devriese, L. A., de Jong, P. A., & de Bree, R. (2020). The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy. Eur Arch Otorhinolaryngol.
Chicago Style CitationHuiskamp, L. F. J., N. Chargi, L. A. Devriese, P. A. de Jong, i R. de Bree. "The Predictive and Prognostic Value of Low Skeletal Muscle Mass for Dose-limiting Toxicity and Survival in Head and Neck Cancer Patients Receiving Concomitant Cetuximab and Radiotherapy." Eur Arch Otorhinolaryngol 2020.
Cita MLAHuiskamp, L. F. J., et al. "The Predictive and Prognostic Value of Low Skeletal Muscle Mass for Dose-limiting Toxicity and Survival in Head and Neck Cancer Patients Receiving Concomitant Cetuximab and Radiotherapy." Eur Arch Otorhinolaryngol 2020.